[Featured Stock] J.Cys Medical Rises 18% on Tender Offer News
JCS Medical's stock price is rising more than 18% following the news of a tender offer.
As of 2:01 PM on the 10th, JCS Medical is trading at 12,770 KRW, up 18.68% (2,010 KRW) from the previous trading day.
The decision by Archimede Group, a French healthcare-focused private equity fund (PEF) manager, to make a tender offer for JCS Medical common shares acted as a positive catalyst. Archimede, established in 2014, is a French PEF manager that primarily invests in healthcare sectors such as biopharmaceuticals, medical technology, and in vitro diagnostics.
JCS Medical announced that its largest shareholder will be changed to Syracuse Subco on this day.
Hot Picks Today
!["Big Gains for Holders... Up 566% and Still More to Go" Target Price Raised, But Here’s Why Caution Remains [Weekend Money]](https://cwcontent.asiae.co.kr/asiaresize/93/2025090513580721483_1757048288.jpg)
"Big Gains for Holders... Up 566% and Still More to Go" Target Price Raised, But Here’s Why Caution Remains [Weekend Money]
- "Data Centers Ignite ESS Order Rally Expectations for This Company [Weekend Money]"
- "Achieving 1 Billion Won Through Stocks" Office Worker Remains Optimistic Despite Mandatory Paid Leave and Halved Salary
- Every Show Sold Out in North America... How Much Did BTS Earn from the Tour?
- "Best Homeroom Teacher"... Hong Kong Education Sector in Shock Over Spread of "Princess Carry" Photos
Syracuse Subco is a corporation newly established in Korea by Archimede in April, and it announced that from today until the 22nd of next month, it will make a tender offer to purchase 55,724,838 common shares of JCS Medical at 13,000 KRW per share. This corresponds to 72.0% of the total potential issued shares of JCS Medical.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
